Vanguard Group Inc Seres Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.64 - $0.91 $139,596 - $198,488	218,119 Added 3.71%	6,091,999 $4.26 Million
Q4 2024 Feb 11, 2025	SELL	$0.55 - $0.98 $102,656 - $182,915	-186,648 Reduced 3.08%	5,873,880 $4.88 Million
Q3 2024 Nov 13, 2024	SELL	$0.7 - $1.48 $157,654 - $333,327	-225,221 Reduced 3.58%	6,060,528 $5.76 Million
Q2 2024 Aug 13, 2024	SELL	$0.56 - $1.19 $251,480 - $534,395	-449,072 Reduced 6.67%	6,285,749 $4.53 Million
Q1 2024 May 10, 2024	BUY	$0.75 - $1.56 $547,135 - $1.14 Million	729,514 Added 12.15%	6,734,821 $5.19 Million
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $491,563 - $1.14 Million	528,563 Added 9.65%	6,005,307 $8.41 Million
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $278,577 - $606,174	119,561 Added 2.23%	5,476,744 $13 Million
Q2 2023 Aug 14, 2023	SELL	$4.67 - $6.55 $2.32 Million - $3.25 Million	-495,953 Reduced 8.47%	5,357,183 $25.7 Million
Q1 2023 May 15, 2023	SELL	$4.95 - $6.09 $1.19 Million - $1.46 Million	-239,801 Reduced 3.94%	5,853,136 $33.2 Million
Q4 2022 Feb 10, 2023	SELL	$5.09 - $9.05 $2.64 Million - $4.69 Million	-517,919 Reduced 7.83%	6,092,937 $34.1 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $4.48 Million - $9.22 Million	1,280,039 Added 24.01%	6,610,856 $42.4 Million
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.62 $712,494 - $2.01 Million	263,887 Added 5.21%	5,330,817 $18.3 Million
Q1 2022 May 13, 2022	BUY	$6.3 - $8.84 $2.46 Million - $3.45 Million	390,665 Added 8.35%	5,066,930 $36.1 Million
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $4.33 Million - $8.23 Million	719,993 Added 18.2%	4,676,265 $39 Million
Q3 2021 Nov 12, 2021	BUY	$5.46 - $22.6 $3.01 Million - $12.4 Million	550,702 Added 16.17%	3,956,272 $27.5 Million
Q2 2021 Aug 13, 2021	BUY	$18.46 - $24.36 $62.9 Million - $83 Million	3,405,570 New	3,405,570 $81.2 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

1.79M

Call Options Held

Put Options Held

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $1.92B
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account